Physician
Family Medicine
Dr. Gerard P. Brennan, MD
|
|
Give Review
Doctor Gerard P. Brennan, MD is an expert in the field of Family Medicine. He researched medicine at University of Louisville School of Medicine. University of Louisville School of Medicine has a rank of 83 in research and a 0 in primary care Gerard P. Brennan, MD is a published doctor and has 99 publications published. The lastest was: 'Observations on the mechanism of eggshell formation in the liver fluke, Fasciola hepatica.'
Publications
- Vitalizing Practice Through Research and Research Through Practice: The Outcomes of a Conference to Enhance the Delivery of Care.
- Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole.
- Utilization and clinical outcomes of outpatient physical therapy for medicare beneficiaries with musculoskeletal conditions.
- A pilot study examining the effectiveness of physical therapy as an adjunct to selective nerve root block in the treatment of lumbar radicular pain from disk herniatio...
- Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
- Description of clinical outcomes and postoperative utilization of physical therapy services within 4 categories of shoulder surgery.
- Does continuing education improve physical therapists' effectiveness in treating neck pain? A randomized clinical trial.
- Physical therapy for acute low back pain: associations with subsequent healthcare costs.
- Is there a subgroup of patients with low back pain likely to benefit from mechanical traction? Results of a randomized clinical trial and subgrouping analysis.
- Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists?
- Preliminary examination of a proposed treatment-based classification system for patients receiving physical therapy interventions for neck pain.
- Impact of continuing education interventions on clinical outcomes of patients with neck pain who received physical therapy.
- Sex differences in predictors of outcome in selected physical therapy interventions for acute low back pain.
- Does the evidence for spinal manipulation translate into better outcomes in routine clinical care for patients with occupational low back pain? A case-control study.
- Identifying subgroups of patients with acute/subacute "nonspecific" low back pain: results of a randomized clinical trial.
- An examination of the reliability of a classification algorithm for subgrouping patients with low back pain.
- Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastro...
- Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.
- Molecular characterization, expression and localization of tropomyosin and paramyosin immunodominant allergens from sheep scab mites (Psoroptes ovis).
- Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis.
- Ultrastructure of the surface structures of Allodiscocotyla diacanthi (Polyopisthocotylea: Monogenea) from the gills of the marine teleost fish, Scomberoides tol.
- Ultrastructure of the surface structures and haptor of Empleurosoma pyriforme (Ancyrocephalinae; Monopisthocotylea: Monogenea) from the gills of the teleost fish Thera...
- High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
- Eukaryotic expression of recombinant Pso o 1, an allergen from Psoroptes ovis, and its localization in the mite.
- Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhi...
- Are preventive drugs preventive enough? A study of patients'' expectation of benefit from preventive drugs.
- Purification and immunochemical studies of dipeptidyl peptidase IV from bovine kidney.
- Ultrastructural localization of peptides using immunogold labeling.
- Ultrastructure of the gut caecal epithelium of Pricea multae (Monogenea: Polyopisthocotylea).
- Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.
- Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
- The ultrastructure and immunogold labelling of pancreatic polypeptide-immunoreactive cells associated with the egg-forming apparatus of a monogenean parasite, Diclidop...
- Localisation, quantitation, and characterisation of neuropeptide F- and FMRFamide-immunoreactive peptides in turbellarians and a monogenean: a comparative study.
- Ultrastructural localization of pancreatic polypeptide- and FMRFamide immunoreactivities within the central nervous system of the nematode, Ascaris suum (Nematoda: Asc...
- Isolation, localization, and bioactivity of the FMRFamide-related neuropeptides GYIRFamide and YIRFamide from the marine turbellarian Bdelloura candida.
- Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
- Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola h...
- Immunomicroscopical observations on the nervous system of adult Eudiplozoon nipponicum (Monogenea: Diplozoidae).
- Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
- Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
- Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
- Physical characteristics of patients with herniated intervertebral lumbar discs.
- The effects of aerobic exercise after lumbar microdiscectomy.
- Ultrastructure of the surface structures and electron immunogold labeling of peptide immunoreactivity in the nervous system of Pseudothoracocotyla indica (Polyopisthoc...
- Neuropeptide F-immunoreactivity in the tetrathyridium of Mesocestoides corti (Cestoda: Cyclophyllidea).
- Grillotia erinaceus (Cestoda, Trypanorhyncha): localization of neuroactive substances in the plerocercoid, using confocal and electron-microscopic immunocytochemistry.
- Neuropeptide F (Moniezia expansa): localization and characterization using specific antisera.
- Immunocytochemical localization of neuropeptide F-immunoreactivity in the circumoesophageal ganglia of the gastropod mollusc, Helix aspersa using electron microscopy.
- Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.
- Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
- Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ ...
- Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica.
- Ultrastructural and histochemical observations on the tegument of Gastrodiscoides hominis (Paramphistoma: Digenea).
- Studies on the ultrastructure and histochemistry of the lymph system of Gastrodiscoides hominis (Paramphistoma: Digenea).
- Understanding triclabendazole resistance.
- Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica.
- Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
- Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
- A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
- An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
- A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.
- Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
- Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
- Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
- Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
- Neuropeptide F-immunoreactivity in the monogenean parasite Diclidophora merlangi.
- Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).
- Observations on the mechanism of eggshell formation in the liver fluke, Fasciola hepatica.
- Electron immunogold labeling of regulatory peptide immunoreactivity in the nervous system of Moniezia expansa (Cestoda: Cyclophyllidea).
- Comparative analyses of the neuropeptide F (NPF)- and FMRFamide-related peptide (FaRP)-immunoreactivities in Fasciola hepatica and Schistosoma spp.
- Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsu...
- Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
- Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with...
- A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica.
- Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
- Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).
- Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.
- Development of the vitellaria of the liver fluke, Fasciola hepatica in the rat host.
- Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasc...
- Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
- Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
- Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, ...
- Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flu...
- Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
- Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental...
- Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
- Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica.
- Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
- Ultrastructural localisation of FMRFamide- and pancreatic polypeptide-immunoreactivities within the central nervous system of the liver fluke, Fasciola hepatica (Trema...
- Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).
- Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
- Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compou...
- The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration.
- Predictive validity of initial fear avoidance beliefs in patients with low back pain receiving physical therapy: is the FABQ a useful screening tool for identifying pa...
- Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.
- Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole.
- A randomized clinical trial of the effectiveness of mechanical traction for sub-groups of patients with low back pain: study methods and rationale.
- Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
Schools
University of Louisville School of Medicine
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Golden Rule
- Health Alliance
- Medicare Advantage PFFS
- Choice Care PPO
- Medicaid
- Medicare MCR
- Priority PPO
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Louisville School of Medicine
Drug Facts
| NPI NUMBER | 1003901034 | |
| NPPES Provider LastName | BRENNAN | |
| NPPES Provider FirstName | GERARD | |
| NPPES Provider ZIPCode | 494453299 | |
| NPPES Provider State | MI | |
| Specialty Description | Family Practice | |
| Total Claim Count | 4400.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 382.0 | |
| Percent Opioid Claims | 8.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003901034 |
| Last Name Of The Provider | BRENNAN |
| First Name Of The Provider | GERARD |
| View All |
Similar Doctors
|
|
Dr. Kristen K. Brown, MD |
|
|
Dr. Brian S. Burdo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd W. Rexford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert P. Vermaire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel J. Jarvis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol Southland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Banka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly S. Briden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lloyd J. Lemmen, MD |
|
|
Dr. Darryl R. Stevens, DO |